Advisors Asset Management, Inc. Arcturus Therapeutics Holdings Inc. Transaction History

Advisors Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$12.26 - $31.17 $39,636 - $100,772	-3,233 Reduced 58.12%	2,330 $37,000
Q1 2022 May 17, 2022	SELL	$17.64 - $39.57 $93,597 - $209,958	-5,306 Reduced 48.82%	5,563 $150,000
Q4 2021 Feb 15, 2022	SELL	$34.2 - $47.56 $15,492 - $21,544	-453 Reduced 4.0%	10,869 $402,000
Q3 2021 Nov 12, 2021	BUY	$27.88 - $58.25 $278 - $582	10 Added 0.09%	11,322 $541,000
Q2 2021 Jul 30, 2021	BUY	$25.79 - $42.11 $124,720 - $203,643	4,836 Added 74.68%	11,312 $383,000
Q1 2021 May 07, 2021	BUY	$38.75 - $86.92 $157,247 - $352,721	4,058 Added 167.82%	6,476 $267,000
Q4 2020 Feb 12, 2021	BUY	$34.61 - $123.66 $83,686 - $299,009	2,418 New	2,418 $105,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.